Trial Profile
Phase 2, Double-blind, Randomized, Parallel-group, Placebo-controlled, Multicenter Study, Comparing Budesonide pMDI 160 microg Bid With Placebo: a 6-week Efficacy and Safety Study in Children Aged 6 to <12 Years With Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms CHASE-1
- Sponsors AstraZeneca
- 09 Oct 2015 Results published in the Annals of Allergy, Asthma and Immunology
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2012 Planned End Date changed from 1 Dec 2011 to 1 Mar 2013 as reported by ClinicalTrials.gov.